Financhill
Back

Upbound Group, Inc. Vs. Novo Nordisk A/S Industry Stock Comparison

Sell
23

UPBD
Upbound Group, Inc.

Last Price:
$17.55
Seasonality Move:
12.47%
Sell
27

NVO
Novo Nordisk A/S

Last Price:
$36.97
Seasonality Move:
12.55%
Sell
23
Upbound Group, Inc. (UPBD) is a Sell

Is Upbound Group, Inc. a Buy, Sell or Hold?

  • The current Upbound Group, Inc. [UPBD] share price is $17.53. The Score for UPBD is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • UPBD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Novo Nordisk A/S (NVO) is a Sell

Is Novo Nordisk A/S a Buy, Sell or Hold?

  • The current Novo Nordisk A/S [NVO] share price is $36.98. The Score for NVO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UPBD Stock Price Chart

What is Upbound Group, Inc.'s stock price today?

  • The Upbound Group, Inc. share price today is $17.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UPBD is experiencing slight buying pressure.

NVO Stock Price Chart

What is Novo Nordisk A/S's stock price today?

  • The Novo Nordisk A/S share price today is $36.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

UPBD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 37.48 Sell
Chaikin Money Flow: 183018 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.52 - 19.92) Sell
Bollinger Bands (100): (17.41 - 20.19) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.87 Sell
Relative Strength Index (14 RSI): 39.83 Sell
Chaikin Money Flow: 14566902 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.41 - 38.59) Sell
Bollinger Bands (100): (39.84 - 55.48) Sell

UPBD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.09 Sell
20-day SMA: 18.19 Sell
50-day SMA: 19.52 Sell
200-day SMA: 21.32 Sell
8-day EMA: 17.96 Sell
20-day EMA: 18.42 Sell
50-day EMA: 19.04 Sell
200-day EMA: 21.09 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.4 Buy
20-day SMA: 37.4 Sell
50-day SMA: 44.19 Sell
200-day SMA: 53.09 Sell
8-day EMA: 36.61 Buy
20-day EMA: 37.8 Sell
50-day EMA: 42.18 Sell
200-day EMA: 54.43 Sell

Upbound Group, Inc. Earnings Growth & UPBD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.15 per share, an increase this year of $0.10 per share, and an increase next year of $0.64 per share.

Novo Nordisk A/S Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.29 per share, and an increase next year of $0.05 per share.

Upbound Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk A/S Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):